Back to Journals » Clinical Ophthalmology » Call For Papers
Clinical Ophthalmology
ISSN: 1177-5483
The following Article Collections/ Thematic Series are currently open for submissions:
Emerging Trends in Digital Ophthalmology and Social Media
Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Emerging Trends in Digital Ophthalmology and Social Media" in Clinical Ophthalmology.
The prevalence of social media use globally has resulted in a profound shift in how patients access and interact with health information. Studies show that 75% of patients turn to social media as their first resource for health-related inquiries. This trend has led many to use online information as a substitute for professional consultations.
New digital and AI-based technologies have also broadened patients' understanding of and access to eye health screening and treatment modalities. Increased digital access to health information can have a significant influence on patients' health-related behaviors, whether positively or negatively. All of this underscores a concerning gap in the professional oversight of health-related content obtained via these platforms.
More research is needed to evaluate digital platforms and the type of ophthalmology content trending online (including the prevalence of misinformation) in order to optimize patient education and encourage practices that promote eye health.
Misinformation amongst ophthalmology-related content on social media is rampant. The medical community has been slow to leverage social media as a tool for health education. Although 70% of physicians are active on social media, only a small fraction—around 10%—are involved in content creation. This disparity highlights a missed opportunity for clinicians to provide evidence-based, reliable health information to a vast audience, especially in the face of widespread misinformation online.
Given these dynamics, it is important for ophthalmologists to better understand emerging digital technologies, social media usage, and trending online topics in the eyecare space to improve patient education and guide patients toward more informed decision-making.
This Article Collection will explore the intersection between digital platforms and eye care. Key areas include the impact of social media on public awareness of eye health, the role of online communities in supporting patients with ocular diseases, and the effectiveness of social media campaigns in promoting preventive eye care.
This Article Collection will also focus on the accuracy of health information shared online, as well as misinformation and its effects on patient behavior and treatment outcomes.
Subtopics may include, but are not limited to:
- The use of telemedicine and virtual consultations in ophthalmology.
- The engagement of ophthalmologists in social media content creation.
- Ethical considerations regarding patient privacy and professional conduct in digital spaces.
- The influence of social media on medical education.
- The adoption of new digital technologies within the field of ophthalmology.
Both original research and review articles are welcome.
All manuscripts submitted to this Article Collection will undergo full peer-review; Guest Advisors will not be handling submitted articles. Please review the journal’s aims and scope and author instructions prior to submission.
Please submit your manuscript through the Dovepress website. During submission, enter the promo code EOQPN for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.
The manuscript submission deadline is 1 November 2025. If you have any questions about this Article Collection, please contact Krista Thom at [email protected].
Guest adviser
Dagny Zhu, MD, NVISION Eye Centers, Rowland Heights, California, USA
Advances in Intraocular Lenses
Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Advances in Intraocular Lenses" in Clinical Ophthalmology.
We recently celebrated 75 years of intraocular lenses (IOLs), which were first implanted by Sir Harold Ridley in 1949. Refractive cataract surgery continues to evolve rapidly, with new surgical technologies constantly emerging. The advanced optics of premium IOLs not only enhance the patient's quality of vision but also their overall quality of life and independence from glasses.
Artificial intelligence has introduced a new generation of formulas that provide exceptionally accurate IOL power calculations. By understanding the design philosophies and clinical performances of newer IOLs, we can better guide patients toward achieving optimal visual outcomes tailored to their specific vision needs.
Recent advancements have led to significant improvements in intermediate vision through the use of trifocal IOLs, extended depth of focus (EDOF) IOLs, monofocal-plus IOLs, light adjustable lenses (LAL), and toric IOLs. These options have improved visual acuity for many patients and resulted in a high level of satisfaction.
Despite the many articles published on IOLs, important challenges remain in synthesizing clinical evidence. Common issues include meta-analyses comparing lens categories with only one or a few lenses per category, inconsistent publication of results, a lack of secondary analyses segmented by biometric data that could enhance selection criteria, and insufficient long-term results. Moreover, new IOLs and variations of existing IOLs are launched each year, which require clinical evidence to develop evidence-based recommendations for their use.
This Article Collection aims to provide readers with the latest advancements and current knowledge in IOLs. We welcome original research and review articles (including meta-analyses and systematic reviews) related to the suggested topics, though submissions are not limited to these areas:
- Outcomes of newer IOLs, focusing on secondary endpoints such as defocus curves, contrast sensitivity, and patient-reported outcomes
- Advanced IOLs, including trifocal IOLs, EDOF IOLs, monofocal-plus IOLs, LAL, toric IOLs, and any emerging options
- Design features related to IOL construction and fixation sites; materials used for optics, filters, and haptics
- Outcomes of supplementary (piggyback) IOLs, customized IOLs, and secondary IOLs
- Considerations for IOLs used in the pediatric population
- Advancements in IOL power calculation
- Innovations in the field of refractive cataract surgery and IOLs
All manuscripts submitted to this Article Collection will undergo full peer-review; Guest Advisors will not be handling submitted articles. Please review the journal’s aims and scope and author instructions prior to submission.
Please submit your manuscript through the Dovepress website. During submission, enter the promo code DXQSW for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.
The manuscript submission deadline is 1 November 2025. If you have any questions about this Article Collection, please contact Krista Thom at [email protected].
Guest adviser
Dr. Mithun Thulasidas, Trinity Eye Hospital, Kerala, India
Femtosecond Laser in Lens Surgery: Contribution to Emmetropia
Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Femtosecond Laser in Lens Surgery: Contribution to Emmetropia" in Clinical Ophthalmology.
The achievement of emmetropia has been one of the oldest dreams in ophthalmology. This goal involves the correction of any refractive error, and by extension, age-related presbyopia. It is also presently established that lens surgery holds the title of the best available and definitive technique to address presbyopia correction, whether in the presence of a cataract or a transparent crystalline lens. In this quest, femtosecond laser technology arose, enabling competing indexes of reproducibility, precision, efficacy, and customization regarding the several steps involved in lens surgery. The present Article Collection will serve the purpose of providing further illumination on the role of femtosecond laser in lens surgery and stimulating new developments of this technology.
The advent of premium IOLs in the context of refractive lens exchange has triggered demands for a higher standard of surgical procedure; hence the concept of premium lens surgery. Cataract surgery itself has shifted goals in the direction of the best refractive correction. Independency of spectacles by means of surgical intervention has become the desire of an increasingly significant part of the population. The high levels of reproducibility and customization of femtosecond laser-assisted technology are liable to open new horizons in the domain of refractive lens surgery.
Topics of interest include:
- Approaches to the different types of femtosecond laser (fs) pulse energy pattern (low or high) reporting their similarities and differences in all kinds of outcomes.
- Reviews (preferably systematic) and/or meta-analyses on the subject with well-defined references to the studied fs platform(s).
- Emphasis on the refractive outcomes of femtosecond laser-assisted lens surgery, either in the context of cataract or, preferably, refractive lens exchange.
- New incomes to premium lens surgery, in the context of femtosecond laser lens surgery, such as Artificial Intelligence (AI).
- Further developments on fs technology as to permit “zero” phaco, i. e., the feasibility of femtosecond machine’s full autonomy.
- Improvements on fs platforms (portability) and cost-effectiveness strategies.
- The birth of new premium IOLs, as thrusted by fs technology.
We welcome original research articles, reviews, editorials, commentaries, clinical trial reports, and protocols. Please note that all meta-analyses require a pre-submission check. Complete the pre-submission check form before submitting.
All manuscripts submitted to this Article Collection will undergo full peer-review; Guest Advisors will not be handling submitted articles. Please review the journal’s aims and scope and author instructions prior to submission.
Please submit your manuscript through the Dovepress website. During submission, enter the promo code PCKXI for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.
The manuscript submission deadline is 1 November 2025. If you have any questions about this Article Collection, please contact Krista Thom at [email protected].
Guest advisers
Dr. Ramiro Salgado, NewClinics, Porto, Portugal
Prof. Antonio A. P. Marinho, Hospital Luz Arrabida, Portugal
Prof. Dr. Alireza Mirshahi, Dardenne Eye Hospital, Bonn, Germany
Translating Science to Practice in Uveitis: A Step-by-Step Clinical Guide Across the Disease
Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Translating Science to Practice in Uveitis: A Step-by-Step Clinical Guide Across the Disease" in Clinical Ophthalmology.
Uveitis represents a diverse group of intraocular inflammatory diseases affecting both children and adults. It remains a leading cause of preventable vision loss worldwide, with varied presentations, etiologies, and systemic associations that pose significant clinical challenges. This Article Collection aims to serve as a comprehensive, step-by-step guide for clinicians managing uveitis across its full spectrum—from diagnosis to long-term care. As diagnostic technologies and therapeutic options evolve, there is a growing need for practical, evidence-based frameworks that support real-world clinical decision-making. The increasing use of multimodal imaging, laboratory investigations, systemic screening, and artificial intelligence (AI) tools has transformed the approach to uveitis. Pediatric uveitis, in particular, demands special attention due to its unique disease patterns, treatment challenges, and impact on long-term visual outcomes. This Collection seeks to translate emerging science into accessible clinical practice, enabling better patient care across various healthcare settings.
This Article Collection is developed in partnership with Clinical Ophthalmology and the PROTON (Program for Ocular Inflammation and Infection Translational Research) Group, a global network dedicated to advancing ocular inflammation research and implementation. PROTON connects clinician-scientists and researchers to promote multidisciplinary, translational approaches. We invite submissions including original research, clinical reviews, diagnostic and treatment algorithms, expert consensus guidelines, pediatric-focused studies, and innovations in digital health and AI. Contributions spanning infectious and non-infectious uveitis, anterior to posterior involvement, systemic associations, imaging, therapeutics, and multidisciplinary care models are encouraged.
Topics may include, but are not limited to:
- Infectious and non-infectious uveitis
- Anterior to posterior disease
- Pediatric uveitis
- Multimodal imaging
- Systemic workup strategies
- Biologics and small molecules
- Long-term monitoring tools
Contributions from ophthalmologists, rheumatologists, immunologists, pediatric specialists, and data scientists are especially welcome. Together, we aim to curate a pragmatic, high-impact, and forward-looking resource that enhances clinical practice and patient care in uveitis across all age groups and disease severities.
All manuscripts submitted to this Article Collection will undergo full peer-review; Guest Advisors will not be handling submitted articles. Please review the journal’s aims and scope and author instructions prior to submission.
Please submit your manuscript through the Dovepress website. During submission, enter the promo code 790D1 to indicate that your submission is for consideration in this Article Collection. Please note that normal Article Processing Charges will apply.
The manuscript submission deadline is 15 February 2026. If you have any questions about this Article Collection, please contact Krista Thom at [email protected].
Guest advisers
Prof. Rupesh Agrawal, Tan Tock Seng Hospital, Singapore
Prof. Vishali Gupta, Post Graduate Institution for Medical Education and Research, Chandigarh, India
Prof. Alejandra de-la-Torre, School of Medicine and Health Sciences Universidad Del Rosario, Bogota, Colombia
Call For Papers
To see where Clinical Ophthalmology is indexed online view the Journal Metrics.
What is the advantage to you of publishing in Clinical Ophthalmology?
- It is an open access journal which means that your paper is available to anyone in the world to download for free directly from the Dove website.
- Although Clinical Ophthalmology receives a large number of papers, unlike many traditional journals, your paper will not be rejected due to lack of space. We are an electronic journal and there are no limits on the number or size of the papers we can publish.
- The time from submission to a decision being made on a paper can, in many journals, take some months and this is very frustrating for authors. Clinical Ophthalmology has a quicker turnaround time than this. Generally peer review is complete within 3-4 weeks and the editor’s decision within 2-14 days of this. It is therefore very rare to have to wait more than 6 weeks for first editorial decision.
- Many authors have found that our peer reviewer’s comments substantially add to their final papers.
To recover our editorial and production costs and continue to provide our content at no cost to readers we charge authors or their institution an article publishing charge.
PubMed Central
Clinical Ophthalmology is indexed on PubMed Central (title abbreviation: Clin Ophthalmol). All published papers in this journal are submitted to PubMed for indexing straight away.
Become a Favored Author and receive real benefits
If you haven't already joined the Dove Press Favored Author Program I would encourage you to do so. Why? To receive real benefits like fast-tracking and a personal co-ordinator for your paper, as well as a discount on the publication processing fee. Click here to go through to the Favored Author signup page.
Yours sincerely
Professor Scott Fraser
Editor-in-Chief
Clinical Ophthalmology
Email: Editor-in-Chief
Updated 10 October 2022